BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  SafeHeal(R) Closes Oversubscribed €35 Million Series C Equity Financing

  May 7, 2025

   · 

  4 min read
• Press Releases

  Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate

  May 7, 2025

   · 

  11 min read
• Press Releases

  Nerva Completes Mahana Therapeutics Acquisition to Expand Access to Digital Therapies for IBS

  May 7, 2025

   · 

  2 min read
• Press Releases

  MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity

  May 7, 2025

   · 

  4 min read
• Press Releases

  HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

  May 7, 2025

   · 

  5 min read
• Press Releases

  SK bioscience Joins Korea’s National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

  May 7, 2025

   · 

  4 min read
• Press Releases

  Ansa Biotechnologies Breaks Traditional Synthetic DNA Length Barriers and Redefines Future of Life Science Research

  May 7, 2025

   · 

  4 min read
• Press Releases

  CorFlow Therapeutics Appoints Chris O’Connell as Chairman of the Board of Directors

  May 7, 2025

   · 

  3 min read
• Press Releases

  iECURE to Present Initial OTC-HOPE Clinical Data of ECUR-506 in Ornithine Transcarbamylase Deficiency at Upcoming Medical Meetings

  May 7, 2025

   · 

  4 min read
• Press Releases

  Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004

  May 7, 2025

   · 

  4 min read